“I'm thrilled to attend this liquid biopsy meeting, where the potential to transform cancer patient care and advance our field is truly within reach. This gathering offers an invaluable opportunity to explore the latest innovations, connect with leaders dedicated to pioneering solutions, and pave the way for more precise, personalized approaches to cancer treatment that could change countless lives”

Anneleen Daemen, Executive Director – Translational Medicine, ORIC Pharmaceuticals